Skip to main content
. Author manuscript; available in PMC: 2018 May 9.
Published in final edited form as: Int J Biol Macromol. 2013 Dec 24;64:377–382. doi: 10.1016/j.ijbiomac.2013.12.032

Fig. 2.

Fig. 2

Effect of DHP on intestine immune activity based on the proliferation of bone marrow cells mediated by the supernatant of small intestinal lymphocytes from mice administered DHP orally (A) or by the supernatant of small intestinal lymphocytes from untreated mice cultured in vitro with DHP (B). ‘*’ and ‘**’ indicate the significant difference of P < 0.05 and P < 0.01 as compared with the control, respectively.